Abstract:Brief Introduction Cardiovascular disease is a leading cause of death, while the progression of the disease is closely related to the damaged endothelial cells (ECs) on the vessel wall. Regenerative medicine is now focused on the generation of functional cells to be used to replace those cells, in which induced pluripotent stem cells (iPSCs) have the great potential. iPSCs are an attractive option to derive new, fully functional ECs to regenerate damaged vasculature. Methods In this study we have generated iPSCs from human fibroblasts using viral induction of the four reprogramming transcription factors (OCT4, SOX2, KLF4, and c-MYC) or using a DNA-free integration method based on a single plasmid transfection and neomycin selection. iPSCs generated by plasmid transduction and selection was faster and provided a higher efficiency of colony formation. Colonies obtained using both methods were isolated, expanded and fully evaluated according to the standard criteria of iPSCs characterisation, including morphology, pluripotent marker expression, alkaline phosphatase staining, and teratoma formation. Results Human iPSCs were differentiated towards vascular cell lineages and specific to ECs. To this end, human iPSCs were seeded on collagen IV and cultured in the presence of Vascular Endothelial Growth Factor (VEGF). Time course experiments revealed the ability of iPSCs to differentiate into ECs and also revealed a greater potential to derive ECs from pluripotent cells generated by transient transfection. In an attempt to obtain a pure population of ECs, iPSCs cells were pre-differentiated into an early progenitor stage and CD34 selection was performed. The CD34+ cells were differentiated into ECs demonstrating a higher efficiency and led to greater homogeneity in derived ECs, expressing in high levels endothelial markers such as VE-Cadherin, PECAM1, KDR, eNOS, vWF. During iPSCs differentiation into ECs, the gene SETSIP (similar to SET protein) was found to be up-regulated. In order to define the mechanistic role of SETSIP, the protein was over-expressed and this markedly enhanced EC differentiation. Conversely, when SETSIP was knockdown by shRNA, EC differentiation was significantly suppressed. Importantly, immunofluorescence staining showed a nuclear translocation for SETSIP during EC differentiation and subsequent luciferase assays indicated that SETSIP and not SET protein induced VE-Cadherin transcriptional activation in the ECs. Conclusion In this study we have shown that CD34 positive cells derived from pre-differentiated human iPSCs have the potential to differentiate into ECs. SETSIP appears to have a critical role in this process though control of VE-Cadherin transcriptional activation. Ongoing studies that identify the key mechanisms controlling iPSC-derived EC-differentiation have considerable relevance for regeneration of damaged vasculature in a range of diseases.

Induced pluripotent stem cells attenuate chronic allogeneic vasculopathy in an integrin beta-1-dependent manner

Extracellular vesicles produced by human-induced pluripotent stem cell-derived endothelial cells can prevent arterial stenosis in mice via autophagy regulation

In Vivo Dynamic Metabolic Changes after Transplantation of Induced Pluripotent Stem Cells for Ischemic Injury

Exosomes Derived From Human Induced Pluripotent Stem Cells-Endothelia Cells Promotes Postnatal Angiogenesis In Mice Bearing Ischemic Limbs

Human Induced Pluripotent Stem Cells Derived Endothelial Cells Mimicking Vascular Inflammatory Response under Flow.

Irradiation Induces Homing of Donor Endothelial Progenitor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance

Microfluidic Single-Cell Analysis Shows That Porcine Induced Pluripotent Stem Cell-Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation

Abstract 302: Generation of Patient-Specific Tissue-Engineered Blood Vessels from Nonintegrated Induced Pluripotent Stem Cells

212 HUMAN INDUCED PLURIPOTENT STEM CELLS DIFFERENTIATE INTO PURE POPULATIONS OF ENDOTHELIAL CELLS MEDIATED BY SET SIMILAR PROTEIN THROUGH VE-CADHERIN TRANSCRIPTIONAL ACTIVATION

In Vitro and in Vivo Study on Angiogenesis of Porcine Induced Pluripotent Stem Cell-Derived Endothelial Cells.

The Role Of The Transcription Factor Rbpj In The Development Of Dorsal Root Ganglia And Trigeminal Ganglia

Human-Induced Pluripotent Stem-Cell-Derived Smooth Muscle Cells Increase Angiogenesis to Treat Hindlimb Ischemia

Direct Reprogramming of Fibroblasts into Endothelial Cells Capable of Angiogenesis and Reendothelialization in Tissue-Engineered Vessels

Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration

Chronic nicotine impairs the angiogenic capacity of human induced pluripotent stem cell-derived endothelial cells in a murine model of peripheral arterial disease

Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells

Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI

A Combination of Distinct Vascular Stem/Progenitor Cells for Neovascularization and Ischemic Rescue.

Molecular Imaging Of Induced Pluripotent Stem Cell Immunogenicity With In Vivo Development In Ischemic Myocardium

Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Attenuate Limb Ischemia by Promoting Angiogenesis in Mice